Clinical trials in line for a major post-COVID change: more

In the aftermath of the COVID-19 pandemic, one major change is coming to clinical drug trials: More diversity.

Related Keywords

China , United States , Dallas , Texas , Chinese , Americans , American , David Gerber , Paul Evans , Eli Lilly , Kate Owen , Janelle Sabo , Arthur Caplan , Natalie Schibell , Forrester Schibell , Forrester Research , Haroldc Simmons Comprehensive Cancer Center , Boston University School Of Medicine , York University Grossman School Of Medicine , Global Development Operations , Bristol Myers Squibb , New York University Grossman School , African American , Comprehensive Cancer Center , African Americans , Davos Alzheimer , Boston University School , Han Chinese , Coronavirus Watch , Global Development ,